Skip to main content
Top
Published in: Clinical and Translational Oncology 3/2017

01-03-2017 | Special Article

European edition of the NCCN clinical practice guidelines: relevance of the translation and adaptation into Spanish

Authors: V. Guillem, C. Camps, A. Carrato, E. Díaz-Rubio, P. Gascón

Published in: Clinical and Translational Oncology | Issue 3/2017

Login to get access

Abstract

The NCCN-evidence-based oncology guidelines are consensus-based management documents, to ensure that all patients receive the most appropriate diagnosis, treatment and support services to achieve the best results. However, the use of these guidelines for decision-making by physicians in Spain is sometimes controversial, as treatments or diagnostic procedures are recommended which might not be authorised in our country, or other management options may exist. In March 2015, the ECO Foundation reached an agreement to translate and adapt the NCCN’s clinical practice guidelines in oncology for the Spanish sector. Consequently, ECO is the first European organization to reach an agreement of this type with the NCCN. This agreement will allow all agents involved in managing the cancer patients to have available guidelines that are adapted to the specific needs of Spain.
Literature
3.
go back to reference Field MJ, Lohr KN, editors. Clinical practice guidelines: directions for a new Agency. Institute of Medicine, National Academic Press, Washington D.C.; 1990. p. 58. Field MJ, Lohr KN, editors. Clinical practice guidelines: directions for a new Agency. Institute of Medicine, National Academic Press, Washington D.C.; 1990. p. 58.
10.
go back to reference Zagouri F, Liakou P, Bartsch R, Peccatori FA, Tsigginou A, Dimitrakakis C et al. Discrepancies between ESMO and NCCN breast cancer guidelines: an appraisal. Breast 2015; 24: 513–523. http://www.elsevier.com/brst. Zagouri F, Liakou P, Bartsch R, Peccatori FA, Tsigginou A, Dimitrakakis C et al. Discrepancies between ESMO and NCCN breast cancer guidelines: an appraisal. Breast 2015; 24: 513–523. http://​www.​elsevier.​com/​brst.
Metadata
Title
European edition of the NCCN clinical practice guidelines: relevance of the translation and adaptation into Spanish
Authors
V. Guillem
C. Camps
A. Carrato
E. Díaz-Rubio
P. Gascón
Publication date
01-03-2017
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 3/2017
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-016-1545-6

Other articles of this Issue 3/2017

Clinical and Translational Oncology 3/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine